2012年8月10日星期五

Therapeutic inhibitor of vascular smooth muscle cells

Methods are provided for inhibiting stenosis following vascular trauma or disease in a mammalian host, comprising administering to the host a therapeutically effective dosage of a therapeutic conjugate containing a vascular smooth muscle binding protein that associates in a specific manner with a cell surface of the vascular smooth muscle cell,...

Cabazitaxel 890654-44-1 Bufexamac Bufexamac HDAC Inhibitors

没有评论:

发表评论